The words are used interchangeably in conversation and mean different things in practice. The distinction is worth holding onto, because it determines whether you are on somebody's calendar or your own.
Fixed-length cohorts — typically three to six months — with an application deadline, a structured curriculum, mentorship, a demo day at the end, and frequently money. Some take equity for it; some do not. MedTech Innovator, for instance, offers up to $500K in prizes and takes no equity at all, which is unusual enough to be worth naming.
The defining feature is the deadline. An accelerator is something you have to be ready for on a date somebody else chose.
Open-ended. Space, mentorship, shared facilities and network, usually without direct funding and usually without a fixed end date. You join when you are ready and leave when you have outgrown it.
For health and life-science companies the facilities can matter more than anything else on offer — wet lab access in particular is scarce and expensive, and an incubator that has it is providing something a cheque cannot easily buy.
A reasonable rule: if your constraint is knowing what to do next, an accelerator's structure and deadline pressure will help. If your constraint is somewhere to do it — bench space, equipment, a regulatory-literate neighbour — an incubator is the better fit.
And if your constraint is money, be careful. Neither is a reliable substitute for a raise, and a cohort that consumes six months of founder attention has a real cost even when the programme is free.
Pitch competitions are neither, and are frequently the fastest non-dilutive money available: prize money, no equity, and a compressed timeline. Some are genuinely lucrative. A few charge founders to pitch, which is a practice we flag on the listing wherever we find it.
The On-Ramp tracks accelerators, incubators, pitch competitions and investor conferences relevant to Canadian health founders in one free public calendar, with funded programmes marked and application deadlines shown months ahead of the event itself — because for most of these, the date that matters is the application, not the demo day.
Other questions founders ask us
What non-dilutive funding is available for Canadian healthcare startups? →SR&ED vs IRAP, and should I apply for grants or pitch investors first? →How do I find angel investors in Canada for a health tech startup? →Can US and international investors invest in Canadian startups? →What do the regulatory classifications mean, and why do they change my investor list? →Do Canadian companies qualify for Y Combinator and US accelerators? →What does investment-ready actually mean? →If you are ready to move from general education to actionable insight for your own company, consider your own Capital Roadmap. 159 verified investors and 63 non-dilutive programmes, filtered to your stage, sector and province, with everyone you have already pitched removed — and a guarantee of at least five qualified investors you have not approached, or your money back.
See what matches your company →
Information, not advice. Profiles are compiled from public sources and verified on the date shown; always confirm details with the source before relying on them.